Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Aug 6 (Reuters) - S&P 500 and Dow futures were steady on Thursday after this week's record-breaking rally as investors awaited details on a Middle East peace deal, while Nasdaq futures slipped as
U. S. stock index futures traded with little direction on Thursday as investors monitored diplomatic developments involving Iran, assessed another round of corporate earnings and looked ahead to key labour market data due later this week.
A modest silver lining for headline inflation is overshadowed by one of the central bank's favorite inflationary measures.
Wall Street hit a milestone on Aug. 4 that would normally silence the skeptics. The S&P 500 closed at a record high for the first time since June, and the Nasdaq Composite followed. Both were powered by stronger-than-expected corporate earnings and falling oil prices tied to hopes the Strait of ...
Total earnings for the S&P 500 companies that have reported are up +41.7% from the same period last year on +14.8% higher revenues, reflecting a notably better showing relative to other recent periods.
Axon Enterprise, the S&P 500 maker of Tasers, body cameras and software for law enforcement, continued its resurgence this week ahead of its Q2 report after today's close. This week's jolt higher may mean it could take a stunning report to maintain upward momentum for Axon stock. Earnings growth is up against what looks like a low bar, but that's only because EPS vaulted 77% in the year-ago quarter.
Catalyst's Q2 earnings per share are strained by merger costs and loan declines, but higher net interest income, improving credit quality and deposit growth support results.
Chipotle's share price has swung wildly for two years, and now management is buying back stock aggressively near current levels while Wall Street eyes a 27% upside. The real question is whether the operational recovery has enough traction to survive margin pressure, a fragile consumer, and fresh food safety concerns.
SpaceX and Tesla CEO Elon Musk is famous for his sky-high ambitions, including reaching Mars one day. After SpaceX’s earnings report Tuesday, Musk laid out four more brazen goals for the rocket and artificial-intelligence company, including reaching $1 trillion in revenue in less than five years. SpaceX stock tumbled 8% to $115.29 on Wednesday, while the S&P 500 edged up 0.1%.
Palantir stock has struggled for months, but the company may have just given investors some hope again. Shares of Palantir surged 29.45% on Aug. 4, the trading day after Palantir reported second-quarter results that topped Wall Street's expectations. The company posted adjusted earnings of 41 cents ...
Aug 5 (Reuters) - Wall Street's main indexes opened higher on Wednesday, as hopes of a Middle East peace breakthrough offset the slide in shares of SpaceX and AMD after the upbeat forecasts issued by
Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.
Just like that, cash flow matters to S&P 500 investors. And it's becoming very apparent. Shares of the nine S&P 500 stocks expected to post the most free cash flow this year, like Micron and Chevron, are smashing the rest of the market.
By Johann M Cherian and Shashwat Chauhan Aug 5 (Reuters) - Futures tracking the S&P 500 and the Dow edged up on Wednesday on hopes of a Middle East peace breakthrough, while ones tied to the Nasdaq
August 5 (Reuters) - What matters in U. and global markets today , Editor-at-Large, Finance and Markets For all the doubts and handwringing, the S&P; 500 and Dow Jones are back at record highs after surging on Tuesday amid falling oil prices and the bumper earnings season.
August 5 (Reuters) - Investors are pouring money into U. healthcare stocks, betting that improving earnings, rising dealmaking and attractive valuations will extend the sector's rebound after years of underperformance.
US stock futures edged higher on Wednesday as investors reacted to renewed hopes of easing tensions in the Middle East, while corporate earnings from SpaceX (NASDAQ:SPCX), Advanced Micro Devices (NASDAQ:AMD) and Novo Nordisk (NYSE:NVO) drove significant pre-market trading. Although geopolitical developments supported overall market sentiment, investors also assessed company-specific news, particularly Elon Musk’s latest comments, which weighed on both SpaceX and AMD shares.
Sacrificing additional transparency is a dangerous game to play.
Hard drive makers Sandisk and Western Digital are due to report earnings after the closing bell Wednesday.
Korean memory-chip manufacturer SK Hynix late last month booked roughly $65 billion in profit for the quarter ended June 30, a 13-fold increase from last year. Hynix earned almost as much money in 90 days as it had in the prior 29 years since its IPO, total. The reports, though outstanding on basically every measure, still fell short of Wall Street’s sky-high expectations for chip companies.
Shares plunged 10% after reports tied a food-safety issue to produce at multiple locations, on Aug. 4, 2026.
CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
